Cleopatra Hospital Co (CAI:CLHO) ROCE %: 16.48% (As of Mar. 2026)


CAI:CLHO Cleopatra Hospital Co CAI:CLHO
88 GF Score
Price E£16.80
GF Value E£13.81
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cleopatra Hospital Co ROCE %?

Cleopatra Hospital Co CAI:CLHO -1.18% 88 ROCE % is 16.48% as of Mar. 2026. GuruFocus rates CAI:CLHO with a GF Score™ of 88/100 and a GF Value™ of E£13.81 (Modestly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cleopatra Hospital Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 16.48%.

Cleopatra Hospital Co  (CAI:CLHO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cleopatra Hospital Co ROCE % Related Terms

Cleopatra Hospital Co ROCE % Historical Data

* Premium members only.

The historical data trend for Cleopatra Hospital Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleopatra Hospital Co ROCE % Chart

Cleopatra Hospital Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.48 18.95 25.08 28.98 25.36

Cleopatra Hospital Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.08 28.49 28.24 14.95 16.48
CAI:CLHO
88GF Score
Cleopatra Hospital Co CAI:CLHO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cleopatra Hospital Co ROCE % Calculation

Cleopatra Hospital Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=1546.419/( ( (7589.753 - 2324.447) + (10241.259 - 3310.317) )/ 2 )
=1546.419/( (5265.306+6930.942)/ 2 )
=1546.419/6098.124
=25.36 %

Cleopatra Hospital Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1160.876/( ( (10241.259 - 3310.317) + (10984.689 - 3825.35) )/ 2 )
=1160.876/( ( 6930.942 + 7159.339 )/ 2 )
=1160.876/7045.1405
=16.48 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 16.48% mean?
Cleopatra Hospital Co (CAI:CLHO) has a ROCE % of 16.48% as of Mar. 2026.
Is Cleopatra Hospital Co's ROCE % too high?
Cleopatra Hospital Co's current ROCE % is 16.48%. The Healthcare Providers & Services industry median ROCE % is 6.41. Cleopatra Hospital Co's value of 16.48% is 157.1% above this industry median. Overall, Cleopatra Hospital Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's ROCE % compare to HCA and THC?
Cleopatra Hospital Co's ROCE % of 16.48% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Cleopatra Hospital Co's value of 16.48% is 157.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cleopatra Hospital Co's current ROCE % of 16.48% is 157.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cleopatra Hospital Co's current ROCE % is 16.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£13.81, compared to a current price of E£16.80 — trading 21.7% above its estimated fair value. The current ROCE % is 16.48% and 157.1% above the Healthcare Providers & Services industry median of 6.41. Cleopatra Hospital Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current ROCE % is 16.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?

Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued. The current stock price of E£16.80 is trading 21.7% above its estimated GF Value™ of E£13.81. GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.

Key valuation signals for CAI:CLHO:

  • ROCE %: 16.48%
  • GF Value™: E£13.81 vs. price of E£16.80 (21.7% above fair value)
  • GF Score™: 88/100 with 5 warning signs
  • Industry Position: 157.1% above the Healthcare Providers & Services median

No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cleopatra Hospital Co Business Description

Address 39, 41 Cleopatra street, Heliopolis, Cairo, EGY
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
88GF Score

Get the complete analysis for CAI:CLHO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£16.80
Price
E£13.81
GF Value